Form 4: Inari Medical CEO Andrew Hykes Reports Beneficial Ownership Changes Following Stryker Merger

Andrew Hykes, CEO of Inari Medical, reports changes in beneficial ownership following the merger with Stryker Corporation, where Inari Medical became a wholly-owned subsidiary of Stryker.

Summary

• Andrew Hykes, the President and CEO of Inari Medical, filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
• The filing is related to the merger between Inari Medical and Stryker Corporation, which became effective on February 19, 2025.
• As a result of the merger, each outstanding share of Inari Medical common stock was converted into the right to receive $80.00 in cash.
• Hykes's holdings of common stock, restricted stock units (RSUs), and stock options were all affected by the merger.
• RSUs vested based on deemed achievement of maximum performance and were converted into the right to receive cash.
• Outstanding stock options were canceled and converted into the right to receive cash equal to the difference between the merger consideration ($80.00) and the exercise price of the options.
• Hykes also reported indirect ownership through his children and spouse, which were also impacted by the merger.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The document describes a completed merger, which provides a defined cash value to shareholders and option holders. The certainty of the cash payout is a positive aspect.

Positives

• The merger provided a cash payout of $80.00 per share for Inari Medical shareholders.
• Performance-based restricted stock units vested at maximum performance as a result of the merger.
• Stock options were converted into cash, providing value to option holders.

Negatives

• The merger resulted in the cancellation of outstanding shares of Inari Medical common stock.
• The merger resulted in the cancellation of outstanding stock options of Inari Medical common stock.
• The merger resulted in the cancellation of outstanding restricted stock units of Inari Medical common stock.

Future Outlook

The document describes the completion of the merger, so there are no forward-looking statements about Inari Medical as an independent entity.

Industry Context

The acquisition of Inari Medical by Stryker reflects a trend of consolidation in the medical device industry, where larger companies acquire smaller, innovative firms to expand their product portfolios and market reach.

Comparison to Industry Standards

• Mergers and acquisitions are common in the medical device industry, with companies like Medtronic, Boston Scientific, and Johnson & Johnson frequently acquiring smaller players.
• The $80.00 per share cash consideration is a key metric for evaluating the deal's value compared to other acquisitions in the sector.
• Comparable transactions would include other acquisitions of medical device companies with similar revenue and growth profiles.

Stakeholder Impact

• Shareholders received $80.00 per share in cash.
• Option holders received cash based on the difference between the merger consideration and the exercise price of their options.
• Employees of Inari Medical are now part of Stryker Corporation.

Key Dates

Keywords

Inari Medical, Stryker, Merger, Beneficial Ownership, Form 4, Andrew Hykes, RSUs, Stock Options, Common Stock